Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Patient-specific stem cell lines derived from human parthenogenetic blastocysts

Patient-specific stem cell lines derived from human parthenogenetic blastocysts

US Patent 9920299 · Granted Mar 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Parthenogenic activation of human oocytes for the production of neuronal cells2022
Parthenogenic activation of human oocytes for the production of neuronal cells2022
Parthenogenic activation of human oocytes for the production of neuronal cells2022
Topical skin care compositions and methods2019
Methods of deriving differentiated cells from stem cells2015
Cell culture medium container assembly2015
Generation of an autologous stem cell library from human oocytes parthenogenetic2013
Generation of an autologous stem cell library from human oocytes parthenogenetic2013
Generation of an autologous stem cell library from human oocytes parthenogenetic2013
Methods of deriving definitive endoderm cells from pluripotent parthenogenetic s2012
Cell culture medium container assembly2011
Method of using autologous fibroblasts to promote healing of wounds and fistulas2010